These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
524 related items for PubMed ID: 18821135
1. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time. Khatib R, Johnson LB, Sharma M, Fakih MG, Ganga R, Riederer K. Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135 [Abstract] [Full Text] [Related]
2. Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes. Hawkins C, Huang J, Jin N, Noskin GA, Zembower TR, Bolon M. Arch Intern Med; 2007 Sep 24; 167(17):1861-7. PubMed ID: 17893307 [Abstract] [Full Text] [Related]
3. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. Laupland KB, Ross T, Gregson DB. J Infect Dis; 2008 Aug 01; 198(3):336-43. PubMed ID: 18522502 [Abstract] [Full Text] [Related]
4. Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates. Kok J, O'Sullivan MV, Gilbert GL. J Hosp Infect; 2011 Oct 01; 79(2):108-14. PubMed ID: 21741724 [Abstract] [Full Text] [Related]
6. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome. Khatib R, Johnson LB, Fakih MG, Riederer K, Khosrovaneh A, Shamse Tabriz M, Sharma M, Saeed S. Scand J Infect Dis; 2006 Oct 01; 38(1):7-14. PubMed ID: 16338832 [Abstract] [Full Text] [Related]
8. Staphylococcus aureus bacteremia. Jensen AG. Dan Med Bull; 2003 Nov 01; 50(4):423-38. PubMed ID: 14694855 [Abstract] [Full Text] [Related]
9. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, O'Donnell A, Wagener MM, Yu VL. Medicine (Baltimore); 2003 Sep 01; 82(5):322-32. PubMed ID: 14530781 [Abstract] [Full Text] [Related]
10. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, Fluckiger U. Clin Microbiol Infect; 2006 Apr 01; 12(4):345-52. PubMed ID: 16524411 [Abstract] [Full Text] [Related]
11. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan. Lin SH, Liao WH, Lai CC, Liao CH, Tan CK, Wang CY, Huang YT, Hsueh PR. J Antimicrob Chemother; 2010 Aug 01; 65(8):1792-8. PubMed ID: 20511366 [Abstract] [Full Text] [Related]
15. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J. Clin Infect Dis; 2008 Jan 15; 46(2):193-200. PubMed ID: 18171250 [Abstract] [Full Text] [Related]
16. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged. Barry A, McNicholas S, Smyth E, Humphreys H, Fitzpatrick F. J Hosp Infect; 2010 Nov 15; 76(3):272-3. PubMed ID: 20435374 [No Abstract] [Full Text] [Related]
17. Diagnosis and management of Staphylococcus aureus bacteraemia. Mitchell DH, Howden BP. Intern Med J; 2005 Dec 15; 35 Suppl 2():S17-24. PubMed ID: 16271058 [Abstract] [Full Text] [Related]